Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengde Wu
Observed name:
Chengde Wu∗
Institutions:
Central South University,
WuXi AppTec (China),
Haikou City People's Hospital
Observed institutions:
Central South University,
WuXi AppTec (China),
Haikou City People's Hospital,
University of Houston
OpenAlex ID:
A5110545675
Discovery of TBC11251, a Potent, Long Acting, Orally Active Endothelin Receptor-A Selective Antagonist
1997
·
Chengde Wu
, Ming F. Chan
, et al.
·
Journal of Medicinal Chemistry
·
130
Discovery, Modeling, and Human Pharmacokinetics ofN-(2-Acetyl-4,6-dimethylphenyl)-3-(3,4-dimethylisoxazol-5-ylsulfamoyl)thiophene-2-carboxamide (TBC3711), a Second Generation, ETASelective, and Orally Bioavailable Endothelin Antagonist
2004
·
Chengde Wu
, E. Radford Decker
, et al.
·
Journal of Medicinal Chemistry
·
115
Genetic Algorithm-Optimized QSPR Models for Bioavailability, Protein Binding, and Urinary Excretion
2006
·
Junmei Wang
, George Krudy
, et al.
·
Journal of Chemical Information and Modeling
·
69
TBC3711, an ETA Receptor Antagonist, Reduces Neonatal Hypoxia-Induced Pulmonary Hypertension in Piglets
2001
·
Thérèse Perreault
, John W Berkenbosch
, et al.
·
Pediatric Research
·
42
Design, Synthesis, and Structure−Activity Relationships of Novel Bicyclic Azole-amines as Negative Allosteric Modulators of Metabotropic Glutamate Receptor 5
2010
·
Douglas F. Burdi
, Rachel Hunt
, et al.
·
Journal of Medicinal Chemistry
·
38
Discovery of a First-in-Class Gut-Restricted RET Kinase Inhibitor as a Clinical Candidate for the Treatment of IBS
2018
·
Hilary Schenck Eidam
, John Russell
, et al.
·
ACS Medicinal Chemistry Letters
·
35
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
2020
·
Chengde Wu
, Xiang Rao
, et al.
·
Cancer Medicine
·
34
PDF
Discovery and Evaluation of Pyrazolo[3,4-d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor
2019
·
Xuejun Zhang
, Xijun Sheng
, et al.
·
ACS Medicinal Chemistry Letters
·
30
Acyl Substitution at the Ortho Position of Anilides Enhances Oral Bioavailability of Thiophene Sulfonamides: TBC3214, an ETA Selective Endothelin Antagonist
2001
·
Chengde Wu
, E. Radford Decker
, et al.
·
Journal of Medicinal Chemistry
·
28
Endothelin Antagonists: Substituted Mesitylcarboxamides with High Potency and Selectivity for ETA Receptors
1999
·
Chengde Wu
, E. Radford Decker
, et al.
·
Journal of Medicinal Chemistry
·
26
The discovery and structure—activity relationships of nonpeptide, low molecular weight antagonists selective for the endothelin ETB receptor
1998
·
Ming Fai Chan
, Adam Kois
, et al.
·
Bioorganic & Medicinal Chemistry
·
26
Thiophenesulfonamides as endothelin receptor antagonists
1996
·
B. Raju
, Chengde Wu
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
26
Structure−Activity Relationships of N 2-Aryl-3-(isoxazolylsulfamoyl)-2-thiophenecarboxamides as Selective Endothelin Receptor-A Antagonists
1997
·
Chengde Wu
, Ming F. Chan
, et al.
·
Journal of Medicinal Chemistry
·
20
Discovery of Pyridopyrimidinones as Potent and Orally Active Dual Inhibitors of PI3K/mTOR
2018
·
Tao Yu
, Ning Li
, et al.
·
ACS Medicinal Chemistry Letters
·
15
Recent discovery and development of endothelin receptor antagonists
2000
·
Chengde Wu
·
Expert Opinion on Therapeutic Patents
·
14
2-Aryloxycarbonylthiophene-3-sulfonamides: Highly potent and etA selective endothelin receptor antagonists
1997
·
B. Raju
, Chengde Wu
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
14
Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis
2021
·
Chengde Wu
, Wei Lin
, et al.
·
Translational Cancer Research
·
13
PDF
Halogen substitution at the isoxazole ring enhances the activity of N-(isoxazolyl)sulfonamide endothelin antagonists
1996
·
Ming Fai Chan
, B. Raju
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
12
Novel Synthesis of N-Methyl-1,2-benzosultams, an Unsuspected Demethylative Intramolecular Cyclization Reaction
1998
·
Chengde Wu
·
The Journal of Organic Chemistry
·
11
Discovery of Orally Bioavailable Ligand Efficient Quinazolindiones as Potent and Selective Tankyrases Inhibitors
2021
·
Donghui Qin
, Xiaojuan Lin
, et al.
·
ACS Medicinal Chemistry Letters
·
9
Discovery of 3-Quinazolin-4(3H)-on-3-yl-2,N-dimethylpropanamides as Orally Active and Selective PI3Kα Inhibitors
2020
·
Jiaqiang Dong
, Jingjie Huang
, et al.
·
ACS Medicinal Chemistry Letters
·
9
Discovery of dimethyl pent-4-ynoic acid derivatives, as potent and orally bioavailable DGAT1 inhibitors that suppress body weight in diet-induced mouse obesity model
2018
·
Tao Yu
, Chengde Wu
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
8
A Facile Synthesis of 5-Amino-3-trifluoromethyl-4-methoxycarbonylisoxazole
1998
·
Chengde Wu∗
·
Synthetic Communications
·
8
A 3D QSAR analysis of in vitro binding affinity and selectivity of 3-isoxazolylsulfonylaminothiophenes as endothelin receptor antagonists
1999
·
Qi Chen
, Chengde Wu
, et al.
·
Quantitative Structure-Activity Relationships
·
6
A Highly Practical Route to 7-Hydroxy-1,3-dihydro-2H-1,4-benzodiazepin-2-one fromp-Anisidine
1999
·
Chengde Wu
, Ronald J. Biediger
, et al.
·
Synthetic Communications
·
5
Show more works
View as search
Works count:
36
Citation count:
754
H-index:
14
I10-index:
19
Year
Topic
Type